JASON RODDICK: Open Payments
NPI 1164509899 · LOMA LINDA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$310 in 12 payments from 10 companies in 2025. Trend: 2023 $587 · 2024 $1,607 · 2025 $310
Food & beverage: $310
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 3 | $68 |
| Almirall LLC | 1 | $58 |
| UCB, Inc. | 1 | $33 |
| Incyte Corporation | 1 | $28 |
| Novartis Pharmaceuticals Corporation | 1 | $27 |
| Galderma Laboratories, L.P. | 1 | $24 |
| Arcutis Biotherapeutics, Inc. | 1 | $23 |
| Lilly USA, LLC | 1 | $18 |
| Amgen Inc. | 1 | $16 |
| Regeneron Healthcare Solutions, Inc. | 1 | $15 |
Products named: Klisyri, CIBINQO, Bimzelx, OPZELURA, NEMLUVIO, Zoryve, LITFULO, TALTZ.
Industry payments across CA — which companies pay providers there.
